Interleukin-1β, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides

Journal of Oral and Maxillofacial Surgery

Volumn 61, Issue 10, 2003, Pages 1171-1178

  Alstergren, Per ^a   Benavente, Claudia ^b   Kopp, Sigvard ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; SIALOGLYCOPROTEIN;

ADULT; ARTHRALGIA; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL MEDICINE; FEMALE; HUMAN; INFLAMMATION; MALE; MASTICATION; PAIN ASSESSMENT; PAIN THRESHOLD; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TISSUE INJURY; ARTHRITIS; BLOOD; CHRONIC DISEASE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FACE PAIN; MALOCCLUSION; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; TEMPOROMANDIBULAR JOINT DISORDER;

ARTHRALGIA; ARTHRITIS; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACIAL PAIN; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; OPEN BITE; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 0141482086     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(03)00678-5     Document Type: Article

References (27)

1. Duff GW: Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheumatol Suppl 100:9, 1994
2. Dinarello CA: Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16:457, 1998
3. Jouvenne P, Vannier E, Dinarello CA, et al: Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: Correlations with markers of inflammation and joint destruction. Arthritis Rheum 41:1083, 1998
4. Miller LC, Lynch EA, Isa S, et al: Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341:146, 1993
5. Tatakis DN: Interleukin-1 and bone metabolism: A review. J Periodontol 64:416, 1993
6. Alstergren P, Ernberg M, Kvarnström M, et al: Interleukin-1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility and anterior open bite. J Oral Maxillofac Surg 56:1059, 1998
7. Okeson JP (ed): Orofacial Pain Guidelines for Assessment, Diagnosis and Management. Carol Stream, IL, Quintessence, 1996
8. Deleuran BW, Chu CQ, Field M, et al: Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801, 1992
9. Smith RJ, Chin JE, Sam LM, et al: Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 34:78, 1991
10. Henderson B, Thompson RC, Hardingham T, et al: Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 3:246, 1991
11. Bresnihan B, Alvaro-Gracia JM, Cobby M, et al: Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41:2196, 1998
12. Arend WP: IL-1 antagonista in inflammatory arthritis. Lancet 341:155, 1993
13. Tegelberg A, Kopp S, Huddenius K, et al: Relationship between disorder in the stomatognathic system and general joint involvement in individuals with rheumatoid arthritis. Acta Odontol Scand 45:391, 1987
14. Alstergren P, Ernberg M, Kopp S, et al: TMJ pain in relation to circulating neuropeptide Y, serotonin, and interleukin-1 beta in rheumatoid arthritis. J Orofac Pain 13:49, 1999
15. Alstergren P, Kopp S, Theodorsson E: Synovial fluid sampling from the temporomandibular joint: Sample quality criteria and levels of interleukin-1 beta and serotonin. Acta Odontol Scand 57:16, 1999
16. Kopp S, Alstergren P: Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis. Mediators Inflamm 11:211, 2002
17. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315, 1988
18. Alstergren P, Appelgren A, Appelgren B, et al: Determination of temporomandibular joint fluid concentrations using vitamin B 12 as an internal standard. Eur J Oral Sci 103:214, 1995
19. Alstergren P, Appelgren A, Appelgren B, et al: Measurement of joint aspirate dilution by a spectrophotometer capillary tube system. Scand J Clin Lab Invest 56:415, 1996
20. Åkerman S, Kopp S, Nilner M, et al: Relationship between clinical and radiologic findings of the temporomandibular joint in rheumatoid arthritis. Oral Surg Oral Med Oral Pathol 66:639, 1988
21. Nordahl S, Alstergren P, Eliasson S, et al: Interleukin-1 beta in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. Eur J Oral Sci 106:559, 1998
22. Rooney M, Symons JA, Duff GW: Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 10:217, 1990
23. Takahashi T, Kondoh T, Fukuda M, et al: Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:135, 1998
24. Kubota E, Imamura H, Kubota T, et al: Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55:20, 1997
25. Dawson J, Engelhardt P, Kastelic T, et al: Effects of soluble interleukin-1 type II receptor on rabbit antigen-induced arthritis: Clinical, biochemical and histological assessment. Rheumatology (Oxford) 38:401, 1999
26. Bessis N, Guery L, Mantovani A, et al: The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur J Immunol 30:867, 2000
27. Attur MG, Dave MN, Leung MY, et al: Functional genomic analysis of type II IL-1beta decoy receptor: Potential for gene therapy in human arthritis and inflammation. J Immunol 168:2001, 2002